Literature DB >> 9696327

Endocrinological and pathological entities of the pre-Cushing's syndrome.

Y Kubota1, T Nakada, I Sasagawa, T Izumi, M Ishigooka, T Nishikawa, K Kawai.   

Abstract

The purpose of the study was to clarify the disease entity of pre-Cushing's syndrome. The authors report on the pathological findings and contents of various steroids in the adenomas of three cases of pre-Cushing's syndrome. Oncocytes were found in one adenoma and others were pure clear cell dominant adenomas. All the adenomas contained higher concentrations of precursor steroids than those of five cases of Cushing's syndrome. However, the patterns of increased precursors were quite different among the three cases. Pre-Cushing's syndrome appeared to include several different kinds of disease entities.

Entities:  

Mesh:

Year:  1998        PMID: 9696327     DOI: 10.1007/bf02550304

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

1.  Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.

Authors:  M Reincke; J Nieke; G P Krestin; W Saeger; B Allolio; W Winkelmann
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

2.  Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management.

Authors:  M K McLeod; N W Thompson; M D Gross; A G Bondeson; L Bondeson
Journal:  Am Surg       Date:  1990-07       Impact factor: 0.688

3.  Cortisol secretion by an incidentally discovered nonfunctional adrenal adenoma.

Authors:  H S Beyer; R P Doe
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

4.  Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas.

Authors:  C M Huiras; G B Pehling; R H Caplan
Journal:  JAMA       Date:  1989-02-10       Impact factor: 56.272

5.  Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone.

Authors:  J Hensen; M Buhl; V Bähr; W Oelkers
Journal:  Klin Wochenschr       Date:  1990-06-19

6.  Mechanism of action of spironolactone on adrenocortical function in guinea pigs.

Authors:  J W Greiner; R E Kramer; J Jarrell; H D Colby
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

7.  Some characteristics of human adrenal microsomal 21-hydroxylase activity.

Authors:  M T Gordon; D C Anderson; R Mitchell; W R Robertson
Journal:  J Steroid Biochem       Date:  1985-07       Impact factor: 4.292

8.  Pulmonary oncocytoma: report of a case in conjunction with an immunohistochemical and ultrastructural study.

Authors:  Y Tashiro; Y Iwata; T Nabae; H Manabe
Journal:  Pathol Int       Date:  1995-06       Impact factor: 2.534

9.  Effects of angiotensin II and ACTH on normal and tumourous human adrenocortical cells.

Authors:  W Belmega; W Oelkers; L Belkien; M Shirpai; U Fiedler; R Häring
Journal:  Acta Endocrinol (Copenh)       Date:  1983-09

10.  Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas).

Authors:  F Jockenhövel; W Kuck; B Hauffa; W Reinhardt; G Benker; S Lederbogen; T Olbricht; D Reinwein
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.